Oxurion NV — Major Shareholding Notification 2024

Apr 11, 2024

Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC

Leuven, BELGIUM – April 11, 2024 – 07:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation¹ it has received two transparency notifications as follows:

Oxurion received a first transparency notification on April 10, 2024, from Atlas Special Opportunities, LLC indicating that as of April 1, 2024, it held 1,630,434,782 shares of the then outstanding 9,014,821,287 shares, and therefore crossed above the threshold (15%) by virtue of the purchase of securities. See Annex 1.

Oxurion received a second transparency notification on April 10, 2024, from Atlas Special Opportunities, LLC indicating that as of April 8, 2024, it held 886,039,886 shares of the then outstanding 9,014,821,287 shares, and therefore crossed below the threshold (10%) by virtue of the sale of securities. See Annex 2.

About Oxurion

Oxurion (Euronext Brussels: OXUR) is engaged in developing next-generation standard of care ophthalmic therapies for the treatment of retinal disease. Oxurion is based in Leuven, Belgium. More information is available at www.oxurion.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forwardlooking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. state securities laws.

Oxurion NV	Backstage Communication
Pascal Ghoson	Jurgen Vluijmans
Chief Executive Officer	Partner
Pascal.ghoson@oxurion.com	jurgen@backstagecom.be

For further information please contact:

________

^1. Article 14, first paragraph, of the Law of 2 May 2007 on disclosure of major holdings.

ANNEX 1

olope ID: 10CF68B5 0C1C-4A85-9417-56A33CD0572A Sign Env

FSMA FINANCIAL SERVICES AND MARKETS AUTHORITY	Form TR-1 BE PART I	Transparency notification
1) Status of the notification
	Final
2) Issuer
	Name OXURION
Identification number 0881-620-924
3) Reason for the notification
	Acquisition or disposal of voting securities or voting rights
4) Notification by
	A person that notifies alone
5) Persons subject to the notification requirement
	Name		Address (for legal entities)
	Atlas Special Opportunities LLC		2500 Westchester Avenue, Suite 401, Purchase, NY 10577
	6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies)
	Address (for legal entities) Name
	Please continue entering the information in part II concerning the persons referred to in Sections 5 and 6		Part II
7) Date on which the threshold is crossed
		01/04/2024 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
15
	If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
9,014,821,287
	Please enter the denominator before filling in the data
10) Notified details
A) Voting rights	Previous notification		After the transaction
Holders of voting rights	# of voting rights	Linked to securities	# of voting rights Not linked to the	Linked to securities	% of voting rights Not linked to the
Atlas Special Opportunities LLC	0	1,630,434,782	securities	18.09%	securities
	TOTAL	1,630,434,782	0	18.09%	0.00%

1,630,434,782 1182 1182 118 118 18.09% 18.09% 18.09% 18.09% 118.09% 118.0 Start with "groups" of holders. Add subtotals with Σ, and then finish with the persons who are "alone".
For groups, start with the ultimate controlling natural person or le

DocuSign Envolope ID: 10CF68B5 0C1C-4A85-9417-56A33CD9572A

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
							+
	TOTAL			0	0.00%
3	The totals will be updated once you have clicked on
TOTAL (A & B)			# of voting rights	% of voting rights
			CALQUIATE	1,630,434,782	18.09%

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

Atlas Special Opportunities LLC is not a controlled entity.

12) In case of proxy voting for only one GM

	will cease to hold /		(DD/MM/YYYY
Holder	will hold again	voting rights as of

13) Additional information

On 28 March 2024 (with settlement date on 1 April 2014) All 2012 stares in Operior NY, as a result of Wrich is shareholding decreased of (60,0,447 72 chares (= 18.09%, denominator = 9,014,821,287).

For security reasons, the unsigned form in xlsx format should be
transmitted to trg.fin@fsma.be. You can do this manually
OR if you have MS Outlook at your disposal via the "

In addition, a signed copy in PDF format should also be
transmitted.

ANNEX 2

uSign Envelope ID: BEED37E6 F968 4E73 94E1 7D83B16E13F0

FSMA	FINANCIAL SERVICES AND MARKETS AUTHORITY	Form TR-1 BE PART I	Transparency notification
1) Status of the notification
	Final
2) Issuer
Identification number 0881-620-924	Name OXURION
3) Reason for the notification
	Acquisition or disposal of voting securities or voting rights
4) Notification by
	A person that notifies alone
5) Persons subject to the notification requirement
	Name		Address (for legal entities)
	Atlas Special Opportunities LLC	2500 Westchester Avenue, Suite 401, Purchase, NY 10577
	6) Persons that dispose of voting rights (only to be filled in if art. 7 of the Law applies)
	Name		Address (for legal entities)
	Please continue entering the information in part II concerning the persons referred to in Sections 5 and 6		Part II
7) Date on which the threshold is crossed
	08/04/2024 (DD/MM/YYYY)
8) Threshold that is crossed (in %)
	10
If the holding has fallen below the lowest threshold, you have the option of not entering any numbers in Section 10
9) Denominator
9,014,821,287
	Please enter the denominator before filling in the data
10) Notified details
A) Voting rights	Previous notification After the transaction
Holders of voting rights	# of voting rights	Linked to securities	# of voting rights Not linked to the	Linked to securities	% of voting rights Not linked to the
Atlas Special Opportunities LLC	1,630,434,782	886,039,886	securities	9.83%	securities
	TOTAL	886,039,886	0	9.83%	0.00%

Start with "groups" of holders. Add subtotals with Z, and then finish with the persons who are "alone".
For groups, start with the ultimate controlling natural person or le

DocuSign Envelope ID: BEED37E6-F968-4E73-94E1-7D83B16E13F0

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
	TOTAL			0	0.00%
11	The totals will be updated once you have clicked on
TOTAL (A & B)				# of voting rights	% of voting rights
			CALCULATE	886,039,886	9.83%

11) Full chain of controlled undertakings through which the holding is effectively held, if applicable

Atlas Special Opportunities LLC is not a controlled entity.

12) In case of proxy voting for only one GM

			(DD/MM/YYYY
Holder	will cease to hold / will hold again	voting rights as of

13) Additional information

On 4 April 2024 (with settlement date on 8 April 2006) 14,394,394,394,394,394,394,394,394,399 shares in Oxumon NV, as a result of virich its shareholding decreased b 80,030,8 denominator = 9,014,821,287).

For security reasons, the unsigned form in xlsx format should be
transmitted to trg.fin@fsma.be. You can do this manually
OR if you have MS Outlook at your disposal via the "

In addition, a signed copy in PDF format should also be
transmitted.